BBH icon

VanEck Biotech ETF

111 hedge funds and large institutions have $152M invested in VanEck Biotech ETF in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 31 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less ownership

Funds ownership:

16% less capital invested

Capital invested by funds: $180M → $152M (-$28.5M)

39% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 31

Holders
111
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$9.68M
2 -$9.21M
3 -$5.76M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.73M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.15M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$306K
52
$296K
53
$292K
54
$279K
55
$269K
56
$265K
57
$262K
58
$261K
59
$255K
60
$254K
61
$249K
62
$248K
63
$230K
64
$220K
65
$209K
66
$202K
67
$202K
68
$202K
69
$143K
70
$140K
71
$135K
72
$128K
73
$103K
74
$74K
75
$66.5K